SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.

NCT03131154 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-infectious Anterior Uveitis

Interventions

DRUG: ADX-102 Ophthalmic Solution (0.5%)
DRUG: Vehicle of ADX-102 Ophthalmic Solution

Sponsor

Aldeyra Therapeutics, Inc.